secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexeo Therapeutics, Inc. (LXEO)
CIK:        0001907108
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0000950170-24-078774
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexeo Therapeutics stockholders elect Class I director, ratify KPMG as auditor
------------------------------------------------------------------------------

- Mette Kirstine Agger elected Class I director with 14,499,254 FOR, 7,450,057 WITHHELD, 1,249,160 broker non-votes.
- Ratification of KPMG LLP as auditor for FY2024 passed: 23,194,982 FOR, 3,088 AGAINST, 401 ABSTAIN.
- Annual meeting held virtually on June 25, 2024; no other proposals were voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/0000950170-24-078774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/lxeo-20240628.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-078774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer